| ID | 10422 |
| Vaccine Name | Norovirus P particle and combination vaccines |
| Disease Name | Norovirus Infection |
| Disease Classification | Gastrointestinal |
| Virus Name | Norovirus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Subunit vaccine |
| Vaccine Status | Preclinical |
| Manufacturer | Cincinnati Children’s Hospital Medical Center |
| Year of Manufacturing | NA |
| Manufacturing Country | USA |
| Age | NA |
| Dosage | NA |
| Administration Route | Intranasal |
| Adjuvant | Chitosan, MPL and TNC buffer |
| Target Strain | P domains representing different GI and GII strains |
| Description | Baculovirus vector in E.coli or yeast system |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.cdc.gov/norovirus/downloads/global-burden-report.pdf |
| Additional Links | NA |